ROCHE MULTIPLE SCLEROSIS PILL GETS FDA PRIORITY REVIEW - SEEKINGALPHA
FDA priority review of Roche's multiple sclerosis pill signals accelerated regulatory catalyst.
What changed
FDA priority review of Roche's multiple sclerosis pill signals accelerated regulatory catalyst.
Why it matters
FDA priority review of Roche's multiple sclerosis pill signals accelerated regulatory catalyst. — impact context not separately stored; see What changed.
← Dashboard
Sep 30, 2026 06:34 PM ET